Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Gillatt

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
BJU International|November 12, 2013
The Melbourne Consensus Statement on the early detection of prostate cancerDeclan G Murphy, Thomas Ahlering, William J Catalona, et al.
Scientific Reports|November 3, 2022
Detection of rare prostate cancer cells in human urine offers prospect of non-invasive diagnosisNima Sayyadi, Irene Justiniano, Yan Wang, et al.
Trials|March 8, 2016
Prostate cancer - evidence of exercise and nutrition trial (PrEvENT): study protocol for a randomised controlled feasibility trialLucy Hackshaw-McGeagh, J Athene Lane, Raj Persad, et al.
BMJ Open|July 26, 2023
Implementation of consensus-based perioperative care pathways to reduce clinical variation for elective surgery in an Australian private hospital: a mixed-methods pre-post study protocolLisa Pagano, Cameron Hemmert, Andrew Hirschhorn, et al.
BMJ Open|March 3, 2021
High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trialVisalini Nair-Shalliker, David P Smith, Val Gebski, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|July 12, 2021
Safety and tolerability of Miltuximab<sup>®</sup> - a first in human study in patients with advanced solid cancersDhanusha Sabanathan, Douglas H Campbell, Vicki M Velonas, et al.
Urologic Oncology|April 20, 2020
Development and evaluation of the MiCheck test for aggressive prostate cancerNeal D Shore, Christopher M Pieczonka, R Jonathan Henderson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 13, 2018
ProDiet: A Phase II Randomized Placebo-controlled Trial of Green Tea Catechins and Lycopene in Men at Increased Risk of Prostate CancerJ Athene Lane, Vanessa Er, Kerry N L Avery, et al.
BMJ Open|September 10, 2020
Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trialJulia Wade, Jenny Donovan, Athene Lane, et al.
British Journal of Cancer|December 21, 2025
High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD)Visalini Nair-Shalliker, David P Smith, Val Gebski, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
BJU International|November 12, 2013
The Melbourne Consensus Statement on the early detection of prostate cancerDeclan G Murphy, Thomas Ahlering, William J Catalona, et al.
Scientific Reports|November 3, 2022
Detection of rare prostate cancer cells in human urine offers prospect of non-invasive diagnosisNima Sayyadi, Irene Justiniano, Yan Wang, et al.
Trials|March 8, 2016
Prostate cancer - evidence of exercise and nutrition trial (PrEvENT): study protocol for a randomised controlled feasibility trialLucy Hackshaw-McGeagh, J Athene Lane, Raj Persad, et al.
BMJ Open|July 26, 2023
Implementation of consensus-based perioperative care pathways to reduce clinical variation for elective surgery in an Australian private hospital: a mixed-methods pre-post study protocolLisa Pagano, Cameron Hemmert, Andrew Hirschhorn, et al.
BMJ Open|March 3, 2021
High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trialVisalini Nair-Shalliker, David P Smith, Val Gebski, et al.
Asia Oceania Journal of Nuclear Medicine & Biology|July 12, 2021
Safety and tolerability of Miltuximab<sup>®</sup> - a first in human study in patients with advanced solid cancersDhanusha Sabanathan, Douglas H Campbell, Vicki M Velonas, et al.
Urologic Oncology|April 20, 2020
Development and evaluation of the MiCheck test for aggressive prostate cancerNeal D Shore, Christopher M Pieczonka, R Jonathan Henderson, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 13, 2018
ProDiet: A Phase II Randomized Placebo-controlled Trial of Green Tea Catechins and Lycopene in Men at Increased Risk of Prostate CancerJ Athene Lane, Vanessa Er, Kerry N L Avery, et al.
BMJ Open|September 10, 2020
Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trialJulia Wade, Jenny Donovan, Athene Lane, et al.
British Journal of Cancer|December 21, 2025
High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD)Visalini Nair-Shalliker, David P Smith, Val Gebski, et al.
Pageof 7